Open-Label Efficacy and Safety Study of Pozelimab in Patients With CD55-Deficient Protein-Losing Enteropathy (CHAPLE Disease)
Clinical trial NCT04209634 · COMPLETED
Trial details
- NCT number
- NCT04209634
- Sponsor
- Regeneron Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-27
- Primary completion
- 2021-11-09
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.